понедельник, 13 марта 2017 г.

GlaxoSmithKline plc (GSK) Rating Reiterated by Liberum Capital

GlaxoSmithKline plc (GSK) Rating Reiterated by Liberum Capital


's stock had its "buy" rating reiterated by stock analysts at Liberum Capital in a report released on Thursday. They presently have a GBX 1,900 target price on the stock.



from Biotech News